Optimind Pharma Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA68405U1012
CAD
0.01
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Optimind Pharma Corp. stock-summary
stock-summary
Optimind Pharma Corp.
Pharmaceuticals & Biotechnology
Loon Energy Corporation is a Canada-based international oil and gas exploration and development company. The Company owns interests in certain South American oil and gas assets, which include interests in properties in Colombia that are obtained by way of farm-out agreements, and an interest in a block of exploration lands in Peru. The Company's segments include Colombia and Corporate. Through a farm-in agreement, the Company earned an non-operated participating interest in approximately 60,820 hectare block of land covered by the Buganviles Association Contract between Holywell Resources S.A. and Empresa Colombiana de Petroleos (Ecopetrol). The Company has not conducted any active oil and gas operations. The Company pursues and evaluates exploration and development opportunities in the international oil and gas arena.
Company Coordinates stock-summary
Company Details
1100-700 4 Ave SW , CALGARY AB : T2P 3J4
stock-summary
Tel: 1 403 8752008
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Timothy Elliott
Chairman of the Board
Mr. Norman Holton
President, Chief Executive Officer, Director
Mr. Jock Graham
Director
Mr. Richard Elliott
Independent Director
Mr. Kenneth Heuchert
Independent Director
Michael McVea
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - May 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 1 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

4.69%

stock-summary
Price to Book

-0.55